Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Pancreatic Cancer Metastatic 1 Nasopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Advanced Renal Cell Carcinoma (RCC) 1 Advanced Malignant Solid Tumors 1 Advanced Lung Cancer 1 Advanced Breast Cancer 1

Interventions

toripalimab 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 denileukin diftitox 1 E7777 fusion protein 1 DNA Mismatch Repair 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Turcot syndrome × toripalimab × 30 days × Clear all

NCT06903858 2026-05-22

PICC-3

Sun Yat-sen University

Phase 2 Recruiting

Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡